HPV – Medxy AI

Beyond Cervical Cancer: The Rising Threat of HPV-Linked Oropharyngeal Cancer in Men

By MedXY 09/09/2025

HPV-related oropharyngeal cancer incidence has surpassed cervical cancer, with men facing a 5-10 fold higher risk. Understanding this shift, symptoms, risks, and the critical role of HPV vaccination can transform prevention and early detection.

Wellness & Lifestyle

Six Early Warning Signs Your Body May Be Sending: Precancerous Conditions to Notice and Act On

By MedXY 08/10/2025

Many common disorders are actually precancerous. Learn the stages of cancer development, six precancerous conditions to watch, their risk factors, tests, and practical prevention and management steps.

Clinical Updates Wellness & Lifestyle

Long-Term Outcomes of Transoral Surgery with Risk-Adapted Adjuvant Therapy in HPV-Positive Oropharyngeal Cancer: Results from the E3311 Trial

By MedXY 08/07/2025

The E3311 phase II trial shows excellent long-term survival with deintensified postoperative management after transoral surgery in HPV-associated oropharyngeal cancer, with most patients spared from high-dose radiation and chemotherapy.

Wellness & Lifestyle

Cervical Cancer Risk After 65: Why Continued Screening Matters

By MedXY 07/29/2025

Emerging research reveals heightened risk of cervical cancer in women aged 65 and older, driven by human papillomavirus (HPV). Continued screening is crucial to address increasing incidence and improve outcomes.

Wellness & Lifestyle

Evaluating HPV Vaccination Schedules: A New Perspective on Booster Doses

By MedXY 07/29/2025

Recent research suggests that a 2-dose HPV vaccine regimen offers similar long-term protection against HPV-16 and HPV-18 as the 2+1-dose regimen, challenging the necessity of booster doses.

Wellness & Lifestyle

Understanding HPV Infections: Risks and Realities

By MedXY 07/27/2025

This article explores the common misconceptions and scientific facts about HPV infections, offering insights on prevention and management.